Skip to content
Peptigraph home

KPV Half-Life: How Long It Stays in Your System

How long KPV stays in the body, how that shapes dosing frequency, and what is known about drug testing.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureAnti-inflammatory tripeptideUpdated
Half-life
Not found
No published half-life found (PubMed search, 2 Oct 2026)
Dosing interval
Not reported
Not stated in study abstracts (PubMed search, 2 Oct 2026)
WADA
Unclear
Not named on the 2026 list
Detection window
Not found
None reported as of 2 Oct 2026

KPV half-life

Half-life: no published half-life found (PubMed search, 2 Oct 2026). A half-life depends on the route (under the skin, into a vein, by mouth or nasal spray), so we report it per route with the study it came from.

What half-life means

Half-life is the time it takes for the amount of a drug in the blood to fall by half. After one half-life, about 50% is left; after two, about 25%; after four to five, only a few percent remain.

  • A long half-life lets a drug be dosed less often, for example once a week.
  • A short half-life means levels rise and fall quickly, which is why some peptides are given daily or more often.
  • Effects can outlast blood levels, so half-life alone does not tell you how long a drug works.

What it means for dosing frequency

Study dosing intervals for KPV: not stated in the study abstracts we summarise (PubMed search, 2 Oct 2026). Changing the interval changes how much drug builds up between doses, so it is not a free choice.

Drug tests and sport

WADA status unclear

KPV: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Anti-doping labs use tests built for specific substances. Whether a given test detects KPV, and for how long, is not reported in the anti-doping literature we checked (as of 2 Oct 2026).

Common questions

How long does KPV stay in your system?

We found no published half-life for KPV (PubMed search, 2 Oct 2026). As a rule, most of a dose is cleared after about four to five half-lives.

What is the half-life of KPV?

No published half-life was found in our PubMed search, 2 Oct 2026. We add one with its source and route if a study reports it.

Is KPV on the WADA prohibited list?

It is unclear. KPV: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

More on KPV

Sources

  1. 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  2. 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  3. 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  4. 4PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) (132 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (alpha-MSH[tiab] OR melanocortin[tiab] OR colitis[tiab] OR inflammat*[tiab]) (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (clinical trial[pt] OR randomized[tiab] OR patients[tiab]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.